Skip to main content

Sarissa Consulting LLC

SEC CIK
0001915870
Latest filing
Nov 14, 2022

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Sarissa Consulting LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overviewAll 13F holders of TPTXFull Q3 2022 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q2 2022
Holdings of TPTX by Sarissa Consulting LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−12,000−100.0%Sold outHolders
Q2 202212,000$903.0K1.3%+12,000NewHolders